Piperaquintetraphosphat / Dihydroartemisinin (1) – Eurartesim®

Antimalarial

Characteristics

Start date 21.03.2012
Resolution 03.05.2012
INN Piperaquintetraphosphat/Dihydroartemisinin
Brand name Eurartesim®
Pharm. company Dossier: Sigma-tau Arzneimittel GmbH
New distributor: ALFASIGMA S.P.A.
G-BA Procedure ID F-002
Therapeutic area Infectious diseases Malaria
Reason for procedure not completed: exempted

Associated procedures

Piperaquintetraphosphat / Dihydroartemisinin (1) Eurartesim® Sigma-tau Arzneimittel GmbH Infectious diseases Antimalarial n.d. exempted


<< List of all resolutions